Fenilhidrazin verilen farelerde L-karnitinin karaciğer dokusundaki koruyucu etkisinin araştırılması
Çalışmada fenilhidraziri ile farelerde oluşturulan karaciğer hasarında L-karnitinin koruyucu etkisinin araştırılması amaçlandı. Bu amaçla Swiss albino cinsi fareler, kontrol, fenilhidrazin (40 mg/kg/fare), fenilhidrazin + L-karnitin (40 mg/kg/fare ve 100 mg/kg/fare/gün) ve L-karnitin (100 mg/kg/fare/gün) olmak üzere dört eşit gruba ayrıldı. Periton içi enjeksiyonlar günlük olarak 7 gün boyunca yapıldı. Yedinci günde fareler ötenazi edildi. Karaciğer dokuları toplandı. AST, ALT aktiviteleri ile üre, total protein, kreatinin, demir, total sialik asit (TSA) ve glukoz konsantrasyonları ölçüldü. Fenilhidrazin grubunda karaciğer AST ve ALT aktiviteleri kontrol grubuna göre anlamlı derecede düşük (p
Investigation of protective effect of L-carnitine in the liver tissue of phenylhydrazine given mice
Aim of this study was to investigate the effects of L-carnitine in phenylhydrazine-induced liver damage in mice. For that purpose, twenty-eight Swiss albino mice were divided into four equal groups as follows: Control, 0.5 ml/day 0.9% NaCl, phenylhydrazine (40 mg/kg/day per mouse), phenylhydrazine plus L-carnitine (40 mg/kg phenylhydrazine and 1000 mg/kg L-carnitine per day per mouse) and L-carnitine group (1000 mg/kg per day per mouse). Intraperitoneal injections were carried out daily for 7 days. On day 7, mice were euthanasied and sacrificed, liver tissues were collected and activities of AST, ALT, urea, total protein, creatinin, iron, total sialic acid (TSA) and glucose were determined. Compared to control group, liver AST and ALT activities were significantly lower but urea, total protein, creatinin, iron, TSA and glucose were higher in phenylhydrazine group. However, there was no statistical difference between control group and phenylhydrazine plus L-carnitine group in terms of the status of the parameters measured except urea levels. In conclusion, the present study suggests that L-carnitine possesses protective roles in phenylhydrazine-induced liver damage in mice, possibly by protecting cell membranes of hepatocytes and by binding iron and toxic substances
___
- 1.Rebouche CJ, Engel AG: Tissue distribution of carnitine biosynthetic enzymes in man. Biochim Biophys Acta 630: 22- 29,1980.
- 2.De Vivo DC, Tein I: Primary and secondary disorders of carnitine metabolism. IntlPediatr, 5: 134-141, 1990.
- 3.Ohlenschlâeger G, Berger: L-carnitin, eine körpereigene substanz von interessanter. vielfaltiger therapeutischer Wirkung, Heilpraxis Magazin, 4: 1-5, 1990.
- 4.Oven K, Nelssen QJL, Goodband RD, Weeden TL, Blum SA: Effect of L-carnitine and soybean oil on growth and performance and body composition of early weaned pigs. / AnimSci, 74: 1612-1619, 1996.
- 5.Me Gary JD, Robles-Valdes C, Fister WD: Role of carnitine in hepatic ketogenesis. Proc NatAcadSci, 72: 4385-4388, 1975.
- 6.Famularo G, De Simone C: A new era for carnitine? Immunol Today, 16: 211-213,1995.
- 7.Karbownik M, Reiter RJ, Garcia JJ, Tan DX: Melatonin reduces phenylhydrazine-induced oxidative damage to cellular membranes: Evidence for the involvement of iron Int / Biochem Cell Biol, 32:1 045-1054,2000.
- 8.Djurkovic A, Zaric J, Lusic M, Glisin V, Popovic Z: Differences in rat RBC cytosol induced after in vivo phenylhydrazine treatment. Cell Biol Int, 23(10): 677-683,1999.
- 9.Stocks J, Gutteridge JMC, Sharp RJ, Dorman6-Famularo G, De Simone C: A new era for carnitine? Immunol Today, 16: 211-213,1995.
- 10.Sydow G: A simplified quick method for determination of sialic acid in serum. Biomed Bichim Acta, 44(11/12): 1721- 1723,1985.
- 11.SPSS for Windows, release 6.0, June 17 1993. Copy right (c. SPSS inc. 1989-1993).
- 12.Ferrali M, Signorini C, Caciotti B, Sugherini L, Ciccoli L, Giachetti D, Comporti M: Protection against oxidative damage of erythrocyte membrane by the flavonoid qurcetin and its relation to iron chelating activity. FEBS Lett, 416: 123- 129, 1997.
- 13.Nakai A, Oya A, Kobe H, Asakura H, Yokata A, Koshino T, Araki T: Changes in maternal lipid peroxidation levels and antioxidant enzymatic activities before and after delivery. / Nippon Med Sci, 67(6): 434-439, 2000.
- 14.Eteng MU, Ebong PE, Ettarh RR, Umoh IB: Aminotransferase activity in serum, liver and heart tissue of rats exposed to theobromine. Indian J Pharm, 30(5): 339-342,1998.
- 15.Bolger G, Lapeyre N, Rheaume M, Kibler P, Bousquet C, Garneau M, Cordingley M: Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis. Antiviral Res, 44(3)0 155-165,1999.
- 16.Naughton BA, Moore E, Bush ME, Lapin DM, Dornfest BS: Hemostatic alterations associated with phenylhydrazine- induced anemia in the rat. J Med, 20(5-6): 305-30, 1989.
- 17.Demirdağ K, Bahçecioğlu İH, Özercan İH, Özden M, Yümaz S, Kalkan A: Role of L-carnitine in the prevention of acute liver damage induced by carbon tetrachloride in rats. J Gastroent Hepato, 19(3): 333, 2004.
- 18.Neuman SL, Lin TL, Hester PY: The effect of dietary carnitine on semen traits of .white leghorn roosters. Poultry Sci, 81: 495-503. 2002.
- 19.Kökoğlu E, Sönmez H, Sanoğlu A: İnsan beyin tümörlerinde bir tümör markeri olarak sialik asit. Biyokimya Derg, XI(1): 29,1986.
- 20.Carter A, Martin NH: Serum sialic acid levels in health and disease. J Clin Pathol, 15: 69-72, 1962.
- 21.Taniuchi K, Chifu K, Hayashi N, Nakamachi Y, Yamaguchi N, Miyamoto Y, Doi, K, Baba S, Uchida Y, Tsukadâ Y, Sugimori T: A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactant. Kobe J Med Sci, 27: 91-102, 1981.
- 22.Crook M: The determination of plasma or serum sialic acid. Clin Biochem, 26: 31-38, 1993.
- 23.Baumgartner M, Blum R: L-carnitine. Carnitine-chemistry, biological function and deficiencies. LONZA, Folder Basel, 3- 8, 1996.
- 24.Vince GS, Dean RT: Is enhanced free radical flux associated with increased intracelluler proteolysis? FEB, 216(2): 253- 256, 1987.